THE MATRIX IS SHAKING: THEY CAN’T HIDE THIS ANYMORE. CANCER’S WORST NIGHTMARE JUST GOT PEER-REVIEWED — AND IT’S TWO CHEAP PARASITE PILLS THAT BIG PHARMA WISHES YOU’D NEVER HEAR ABOUT.
Listen, my BWS tribe . While the weak, the scared, and the system slaves are out there pumping chemo poison into their veins, paying hundreds of thousands for treatments that make them feel like death warmed over, real Slaylebrities are waking up. The largest human study yet on ivermectin plus mebendazole for cancer just dropped — peer-reviewed, published in a major oncology journal, Anticancer Research. And the numbers? They’re nuclear.
84.4% Clinical Benefit Ratio.
That’s not some lab rat fantasy. That’s real humans. 197 cancer patients. Diverse cancers — prostate, breast, lung, you name it.
They took compounded capsules: 25mg ivermectin + 250mg mebendazole. Followed for six months.
32.8% declared NO EVIDENCE OF DISEASE.
15.6% saw tumor regression.
36.1% achieved stabilization.
Over four out of five patients saw their cancer either vanish, shrink, or stop growing like a coward. 48.4% got the strongest wins — gone or shrinking. Only 15.6% saw progression. Adherence was elite: 86.9% finished the initial course, 66.4% stayed on it. Side effects? Mild gut stuff in just 25.4%, and almost all kept going after tiny tweaks.
This isn’t some basement mainstream social media post nonsense. This is real-world data from a U.S. telemedicine platform, backed by The Wellness Company, the McCullough Foundation, and even the Chairman of the President’s Cancer Panel. These aren’t conspiracy guys in tinfoil hats — this is frontline observation meeting rigorous publication standards.
Why Does This Work with scary precision?
These aren’t random pills. Ivermectin and mebendazole are old-school antiparasitics that Big Pharma has milked for decades in poor countries. But in the lab? They go full beast mode on cancer cells. They hit multiple pathways — stopping cell division, choking blood supply to tumors (anti-angiogenesis), forcing cancer cells to kill themselves (apoptosis), and more.
Preclinical studies have been screaming this for years. Cancer hates these drugs. They’re multi-target killers in a world where expensive new drugs hit one weak spot and fail.
Real patients mixed it with chemo, radiation, surgery, supplements, and diet changes. Yeah, confounders exist — life isn’t a perfect vacuum. But you don’t wave away 84.4% benefit like it’s nothing. Observational data like this has launched revolutions before. This is the signal. Now we need the trials to confirm it.
The Real Scandal: Why Isn’t This Front Page News?
Because these drugs are off-patent. Cheap. Generic. No billion-dollar profits for pumping patients full of patented poison for the rest of their miserable lives. Sound familiar? Same story as high-dose vitamin C (ascorbate) — solid data, zero incentive for the cartel to run massive Phase 3 trials. Big Pharma doesn’t cure; they manage symptoms and subscriptions.
The system wants you dependent. Sick. Scared. Coming back for the next round of “treatment” that bankrupts your family while they fly private. They laughed at ivermectin during the last big scare. Censored doctors. Destroyed careers. Now the same playbook for cancer?
No one is screaming from the roof tops it’s sickening
Cancer patients are exercising their right to try. They’re not waiting for permission from some bureaucrat or pharma lobbyist who’s never stared death in the face. High adherence, tolerable safety, real-world results across all kinds of cancers. This is hope for the hopeless — the stage 4 warriors, the ones the system already wrote off.
What This Means for You, Top Slaylebrity
If you or someone you love is facing this cancer demon, the message is simple: Take massive action. Research. Talk to doctors open to repurposed therapies. Demand better data. Support calls for proper randomized trials — even if government has to step up because pharma won’t (and they probably won’t).
The matrix fears strong, informed men and women who refuse to be passive victims. They want you compliant, consuming their expensive failures. This study punches a hole right through that lie. 84.4%. Peer-reviewed. Published. Irrefutable signal that the old parasite killers might just be the new cancer slayers.
Share this everywhere. Wake up your circle. The weak will scroll past and stay sick. The strong will dig deeper, question everything, and fight like Slaylebrity lions.
Cancer thought it had the upper hand. Nature just reminded it — and the corrupt system propping it up — that real solutions are often hiding in plain sight, cheap and accessible, waiting for men with balls to use them.
The war on cancer just got a new frontline. And it’s not in some billion-dollar lab. It’s in the blood of people who refused to die on Big Pharma’s schedule.
What are you waiting for? Get informed. Stay relentless. Win.
Link to the study: https://pubmed.ncbi.nlm.nih.gov/42203321/
BWS CONCIERGE out.
HOW TO CONSULT WITH BWS?
Rates: $100 | 30 minute
Contact: TO PARTNER OR FOR CONSULTATION
Emeritus Prof Ifeoma Okoye
Email: sales@slaynetwork.co.uk
Website: https://slaylebrity.com/users/pinkyprof/
Instagram: @pinkyprof_wellness
PS: If you will like to join Slaylebrity VIP social network pls contact sales@slaynetwork.co.uk and include referred by BWS in your subject cheers!
Over four out of five patients saw their cancer either vanish, shrink, or stop growing like a coward.
48.4% got the strongest wins — gone or shrinking.
Only 15.6% saw progression.
Adherence was elite: 86.9% finished the initial course, 66.4% stayed on it. Side effects? Mild gut stuff in just 25.4%, and almost all kept going after tiny tweaks.
This isn’t some basement mainstream social media post nonsense. This is real-world data from a U.S. telemedicine platform, backed by The Wellness Company, the McCullough Foundation, and even the Chairman of the President’s Cancer Panel. These aren’t conspiracy guys in tinfoil hats — this is frontline observation meeting rigorous publication standards.
